Clinical Pathways for Effective and Appropriate Care

A

Agenzia Regionale Sanitaria delle Marche

Status

Completed

Conditions

Stroke

Treatments

Other: Clinical Pathways

Study type

Interventional

Funder types

Other

Identifiers

NCT00673491
DCPIEAC-EXART12MARCHE

Details and patient eligibility

About

The purposes of this study are to determine whether clinical pathways: 1)improve the quality of the care provided to patients affected by stroke in terms of clinical outcomes, efficiency continuity of care and patients' satisfaction; 2) facilitate the use of evidence based medicine in clinical practice.

Full description

The coordination of care has been proved to be able to improve prognosis in acute stroke patients. Prompt identification of symptoms, organised timely and efficient transportation towards appropriate facilities, has become essential part of effective treatment, as well as organized rehabilitation. The importance of organized stroke care in facilitating recovery has been recognized for the last 10 years, but it is still unclear how organized care contributes to improved outcomes. Since clinical pathways aim to promote evidence- and guideline-based care, improve the organisation and efficiency of care, and reduce cost, their implementation may be a method for achieving the organizational standards required to grant appropriate care in stroke. Even though in the past decade, care pathways have been increasingly implemented as a tool in acute stroke care and stroke rehabilitation the evidence supports partially the use of clinical pathways in stroke because very little prospective controlled data demonstrated their effectiveness through the continuum of the care. Our study was designed in order to conduct a rigorous evaluation of clinical pathways for treatment of acute stroke patients in different types of organized stroke care.

Enrollment

448 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Principal diagnosis of Ischemic Stroke (ICD9CM code 434.91)

Exclusion criteria

  • Transient cerebral ischemia (ICD9CM code 435.9)
  • Intracerebral hemorrhage (ICD9CM codes 431.xx)

Trial design

448 participants in 2 patient groups

1
Experimental group
Description:
Patients treated according to clinical pathways
Treatment:
Other: Clinical Pathways
2
No Intervention group
Description:
Patients treated according to usual care

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems